AHCO vs. ADUS, BTSG, EHAB, AVAH, AMED, LGND, GMTX, ALHC, PHR, and IRWD
Should you be buying AdaptHealth stock or one of its competitors? The main competitors of AdaptHealth include Addus HomeCare (ADUS), BrightSpring Health Services (BTSG), Enhabit (EHAB), Aveanna Healthcare (AVAH), Amedisys (AMED), Ligand Pharmaceuticals (LGND), Gemini Therapeutics (GMTX), Alignment Healthcare (ALHC), Phreesia (PHR), and Ironwood Pharmaceuticals (IRWD). These companies are all part of the "medical" sector.
AdaptHealth (NASDAQ:AHCO) and Addus HomeCare (NASDAQ:ADUS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, community ranking, media sentiment, dividends, valuation, analyst recommendations and profitability.
In the previous week, Addus HomeCare had 9 more articles in the media than AdaptHealth. MarketBeat recorded 25 mentions for Addus HomeCare and 16 mentions for AdaptHealth. Addus HomeCare's average media sentiment score of 0.64 beat AdaptHealth's score of 0.28 indicating that Addus HomeCare is being referred to more favorably in the news media.
82.7% of AdaptHealth shares are owned by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are owned by institutional investors. 13.6% of AdaptHealth shares are owned by insiders. Comparatively, 4.6% of Addus HomeCare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Addus HomeCare has lower revenue, but higher earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.
AdaptHealth has a beta of 1.06, suggesting that its share price is 6% more volatile than the S&P 500. Comparatively, Addus HomeCare has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500.
Addus HomeCare received 221 more outperform votes than AdaptHealth when rated by MarketBeat users. Likewise, 67.04% of users gave Addus HomeCare an outperform vote while only 58.91% of users gave AdaptHealth an outperform vote.
Addus HomeCare has a net margin of 6.04% compared to AdaptHealth's net margin of -21.45%. Addus HomeCare's return on equity of 10.03% beat AdaptHealth's return on equity.
AdaptHealth presently has a consensus target price of $12.42, suggesting a potential upside of 28.40%. Addus HomeCare has a consensus target price of $108.57, suggesting a potential downside of 0.63%. Given AdaptHealth's higher possible upside, analysts plainly believe AdaptHealth is more favorable than Addus HomeCare.
Summary
Addus HomeCare beats AdaptHealth on 14 of the 18 factors compared between the two stocks.
Get AdaptHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for AHCO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AHCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AdaptHealth Competitors List
Related Companies and Tools
